Response to the letter to the editor letter to the editor regarding article: “efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literature”
European Archives of Oto-Rhino-Laryngology · 21.11.2026
DOI: 10.1007/s00405-026-10819-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 21.11.2026. Verfasst von Pietro Orlando und 6 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Orlando, P., Flammia, L., Vivarelli, E., Matucci, A., Vultaggio, A., Gallo, O., & Maggiore, G. (2026). Response to the letter to the editor letter to the editor regarding article: “efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literature”. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10819-3
Vancouver
Orlando P, Flammia L, Vivarelli E, Matucci A, Vultaggio A, Gallo O, et al. Response to the letter to the editor letter to the editor regarding article: “efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literature”. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10819-3
BibTeX
@article{Orlando2026,
author = {Orlando, Pietro and Flammia, Letizia and Vivarelli, Emanuele and Matucci, Andrea and Vultaggio, Alessandra and Gallo, Oreste and Maggiore, Giandomenico},
title = {Response to the letter to the editor letter to the editor regarding article: “efficacy and safety of mepolizumab in the treatment of CRSwNP in the real-life setting: a review of the literature”},
journal = {European Archives of Oto-Rhino-Laryngology},
year = {2026},
doi = {10.1007/s00405-026-10819-3}
}
EUVIMED